Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
GlaxoSmithKline
A single-centre, randomized, double-blind placebo-controlled, dose-ascending, cross-over study to evaluate the safety, tolerability, pharmacodynamics and pharmacokinetics of single inhaled doses of GSK233705 (50, 100 and 200µg), formulated with the excipient magnesium stearate, in healthy volunteers.
Age
18–55
Sex
MALE
Healthy volunteers
Accepted
You may be eligible if
Healthy male subjects 18-55 years old
Non-Smokers
You may not be if
Any subject with breathing problems.
High blood pressure and heart abnormalities.
Any subjects currently taking prescription and non-prescription medications.
Clareo Health | A Single Centre Randomized Study Evaluating The Safety And Tolerability Of GSK233705 In Healthy Volunteers.
